An sanya ranar karewa a kan samfurin don tabbatar mana cewa ingancin samfurin yana raguwa. Idan yazo da maganin arthritis , shin ranar karewa kawai ta gargadi mu game da inganci ko kuma yana da rashin lafiya don shan magani na ƙarewa?
Ƙayyadadden kwanan samfurori suna ba da labarin. Idan samfurin yana kusa da ranar karewa, wannan samfurin ya kasance yana kusa da ɗan lokaci kaɗan - kuma ba shi da kima mafi kyau.
Abin sha'awa game da kwanakin karewa, wasu mutane sun watsi da su kuma wasu suna kula da hankali sosai.
Bari muyi amfani da madara a matsayin misali. Lokacin da ka wuce ranar karewa, akwai kyakkyawar damar da za ka haɗu da mummunan rai, m, daɗaɗa mai madara. Mafi nisa da ka samu kwanan wata, mafi muni ya samu. Ba wanda yake so ya shayar da abinci, amma idan an tilasta ka jefa madara wanda ya wuce bayan karewa kuma ya rushe, to, ya kasance. Tambayar game da kwanakin karewa ya zama mafi haɗari lokacin da muke la'akari da samfurori, irin su magani, wanda ke da magungunan magani wanda ya shafi aikin su.
Ba haka ba ne ka ambaci kudin da ake ciki. Yawancin lokaci, marasa lafiya na arthritis sun canza magunguna a kokarin da za su iya sarrafa lafiyarsu ko ci gaba da cutar. Daga baya, zasu iya kawo karshen maganin miyagun ƙwayoyi da suka ajiye. Idan miyagun ƙwayoyi ya zauna har tsawon lokaci, zai iya ƙare. Mene ne ya fi damuwa fiye da zubar da kwayoyi masu tsada?
Ƙarshen kwanan wata magani
A 1979, dokar ta wuce a Amurka wanda ake buƙatar masu yin magungunan ƙwayoyi su zamana kwanakin karewa a kan magunguna da suka samar. Kwanan wata yana wakiltar ma'anar abin da magungunan ƙwayoyi ke iya tabbatar da cikakken iko da aminci na miyagun ƙwayoyi. Amma "zai iya tabbatar da cikakken iko da aminci" yana nufin cewa idan ka dauki miyagun ƙwayoyi fiye da wancan batu ba kyau ko, watakila mafi mahimmanci, rashin lafiya?
Makarantun biyu na Tunanin
Cibiyar Abinci da Drugura ta Amirka (FDA) ta gudanar da wani binciken don gwada kwayoyi bayan sun kare lokacin da sojoji ke fuskanta tare da juyawa da maye gurbin kayayyaki na kwayoyi kowace shekaru ko haka. An gudanar da shirin SLEP (shiri na tsawon rai) ta Cibiyar Abincin da Drugta don Tsaron Tsaro na Amurka (DOD) har tsawon shekaru 20. Bisa la'akari da bayanan bincike na kwanciyar hankali na 3,005 ƙananan magungunan magunguna 122, tun 1986, 88% na kuri'un da aka ƙaddamar fiye da iyakar ranar ƙarshe. Daga cikin kuri'u 2,652, kawai kashi 18% ne kawai suka ƙare saboda rashin nasara. Sauran kuri'a duk da haka har yanzu suna aiki (35%) ko kuma sun ragu (47%) da sojoji.
Hakan ya zama tushen dasu ɗaya na tunani game da magani na ƙare. FDA ta yi gargadin cewa binciken bai yi kama da kwayoyi ba a cikin gidan likitan ku da kyau don tabbatar da cikakkiyar ƙaddamarwa. FDA ta yi la'akari da hankali, kodayake binciken ya kammala cewa - tare da wasu 'yan kalilan kamar tetracycline, nitroglycerin, da kuma insulin - kwayoyi sun tsaya a cikin shekaru masu yawa bayan sun kare.
Wannan shi ne wata makaranta ta tunani: Yana da matukar damuwa don shan magani.
Bisa ga FDA, da zarar ka wuce ranar karewa, babu tabbaci game da tasiri ko aminci.
Layin Ƙasa daga FDA
"Ƙayyadadden kwanan wata akan kayayyakin kiwon lafiyar sune mahimmanci na yanke shawara idan samfurin yana da lafiya don amfani kuma zaiyi aiki kamar yadda aka nufa," in ji likitancin FDA Ilisa Bernstein. Idan maganin ku ya ƙare, kada ku yi amfani da shi.
> Sources:
> Lister, Sherunda. Kada a yi amfani da shi don amfani da Magunguna. Ofishin sadarwa. FDA.gov. 4/25/2011.
> Lyon RC et al. Bayanan ƙwaƙwalwar ajiya na kayan ƙwayar ƙwayoyin cuta fiye da ƙarshen ranar ƙare. Journal of Pharmaceutical Sciences Vol. 95, NO. 7, Yuli, 2006. Aka buga a intanet a Wiley InterScience (www.interscience.wiley.com). DOI 10.1002 / jps.20636.